S&P 500   4,630.99 (-0.52%)
DOW   34,827.40 (-0.88%)
QQQ   400.62 (+0.23%)
AAPL   164.00 (+2.35%)
MSFT   337.48 (+0.25%)
FB   334.07 (-1.17%)
GOOGL   2,916.38 (+0.20%)
AMZN   3,572.84 (+0.32%)
TSLA   1,164.95 (+2.46%)
NVDA   330.92 (-0.85%)
BABA   129.92 (-1.28%)
NIO   40.68 (+0.54%)
CGC   10.89 (-1.54%)
AMD   163.37 (+0.90%)
GE   96.38 (-2.05%)
MU   86.21 (+0.08%)
T   23.13 (-3.18%)
F   19.58 (-0.46%)
DIS   145.64 (-1.47%)
ACB   6.42 (-0.31%)
AMC   35.81 (-2.80%)
PFE   53.43 (+1.97%)
BA   196.11 (-1.20%)
S&P 500   4,630.99 (-0.52%)
DOW   34,827.40 (-0.88%)
QQQ   400.62 (+0.23%)
AAPL   164.00 (+2.35%)
MSFT   337.48 (+0.25%)
FB   334.07 (-1.17%)
GOOGL   2,916.38 (+0.20%)
AMZN   3,572.84 (+0.32%)
TSLA   1,164.95 (+2.46%)
NVDA   330.92 (-0.85%)
BABA   129.92 (-1.28%)
NIO   40.68 (+0.54%)
CGC   10.89 (-1.54%)
AMD   163.37 (+0.90%)
GE   96.38 (-2.05%)
MU   86.21 (+0.08%)
T   23.13 (-3.18%)
F   19.58 (-0.46%)
DIS   145.64 (-1.47%)
ACB   6.42 (-0.31%)
AMC   35.81 (-2.80%)
PFE   53.43 (+1.97%)
BA   196.11 (-1.20%)
S&P 500   4,630.99 (-0.52%)
DOW   34,827.40 (-0.88%)
QQQ   400.62 (+0.23%)
AAPL   164.00 (+2.35%)
MSFT   337.48 (+0.25%)
FB   334.07 (-1.17%)
GOOGL   2,916.38 (+0.20%)
AMZN   3,572.84 (+0.32%)
TSLA   1,164.95 (+2.46%)
NVDA   330.92 (-0.85%)
BABA   129.92 (-1.28%)
NIO   40.68 (+0.54%)
CGC   10.89 (-1.54%)
AMD   163.37 (+0.90%)
GE   96.38 (-2.05%)
MU   86.21 (+0.08%)
T   23.13 (-3.18%)
F   19.58 (-0.46%)
DIS   145.64 (-1.47%)
ACB   6.42 (-0.31%)
AMC   35.81 (-2.80%)
PFE   53.43 (+1.97%)
BA   196.11 (-1.20%)
S&P 500   4,630.99 (-0.52%)
DOW   34,827.40 (-0.88%)
QQQ   400.62 (+0.23%)
AAPL   164.00 (+2.35%)
MSFT   337.48 (+0.25%)
FB   334.07 (-1.17%)
GOOGL   2,916.38 (+0.20%)
AMZN   3,572.84 (+0.32%)
TSLA   1,164.95 (+2.46%)
NVDA   330.92 (-0.85%)
BABA   129.92 (-1.28%)
NIO   40.68 (+0.54%)
CGC   10.89 (-1.54%)
AMD   163.37 (+0.90%)
GE   96.38 (-2.05%)
MU   86.21 (+0.08%)
T   23.13 (-3.18%)
F   19.58 (-0.46%)
DIS   145.64 (-1.47%)
ACB   6.42 (-0.31%)
AMC   35.81 (-2.80%)
PFE   53.43 (+1.97%)
BA   196.11 (-1.20%)

Litchfield Hills Research Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Litchfield Hills Research. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Litchfield Hills Research.

MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyDateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
STRR
Star Equity
11/17/2021Reiterated byLitchfield Hills ResearchAnalyst T. O�NeillBuyHigh
COMS
COMSovereign
11/17/2021Reiterated byLitchfield Hills ResearchAnalyst T. O�NeillBuyLow
POAI
Predictive Oncology
11/16/2021Reiterated byLitchfield Hills ResearchAnalyst T. O�NeillBuyMedium
CODX
Co-Diagnostics
11/15/2021Reiterated byLitchfield Hills ResearchAnalyst T. O�NeillBuyHigh
BELFB
Bel Fuse
11/2/2021Reiterated byLitchfield Hills ResearchAnalyst T. O�NeillBuyMedium
GHM
Graham
10/28/2021Reiterated byLitchfield Hills ResearchAnalyst T. O�NeillBuyLow
AVNW
Aviat Networks
8/27/2021Reiterated byLitchfield Hills ResearchAnalyst T. O�NeillBuyLow
ADIL
Adial Pharmaceuticals
8/26/2021Target Raised byLitchfield Hills ResearchAnalyst Theodore O'NeillBuy$5.00 -> $15.00High
ADIL
Adial Pharmaceuticals
6/29/2021Initiated byLitchfield Hills ResearchAnalyst Theodore O'NeillBuy $5.00Low
POAI
Predictive Oncology
2/1/2021Initiated byLitchfield Hills ResearchBuy $3.00Low
GHM
Graham
4/22/2019Initiated byLitchfield Hills ResearchBuy $1.59Low
TSLA
Tesla
2/18/2014Target Raised byLitchfield Hills Research$37.60 -> $44.40N/A
SWBI
Smith & Wesson Brands
10/10/2013Initiated byLitchfield Hills ResearchBuy $21.00N/A
TSLA
Tesla
8/6/2013Target Raised byLitchfield Hills Research$20.00 -> $37.60N/A
JCI
Johnson Controls International
7/3/2013Initiated byLitchfield Hills ResearchBuy -> Buy$47.00 -> $47.00N/A

MarketBeat Community Rating for Litchfield Hills Research

Community Ranking:  2.8 out of 5 (star star half star)
Outperform Votes:  17,741 (Vote Outperform)
Underperform Votes:  14,119 (Vote Underperform)
Total Votes:  31,860
MarketBeat's community ratings are surveys of what our community members think about Litchfield Hills Research and other research firms. Vote "Outperform" if you believe Litchfield Hills Research's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Litchfield Hills Research's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.